Imaging modalities for diagnosis and monitoring of cancer cachexia.
EJNMMI Res. 11:94 (2021)
Cachexia, a multifactorial wasting syndrome, is highly prevalent among advanced-stage cancer patients. Unlike weight loss in healthy humans, the progressive loss of body weight in cancer cachexia primarily implicates lean body mass, caused by an aberrant metabolism and systemic inflammation. This may lead to disease aggravation, poorer quality of life, and increased mortality. Timely detection is, therefore, crucial, as is the careful monitoring of cancer progression, in an effort to improve management, facilitate individual treatment and minimize disease complications. A detailed analysis of body composition and tissue changes using imaging modalities-that is, computed tomography, magnetic resonance imaging, (18F) fluoro-2-deoxy-D-glucose (18FDG) PET and dual-energy X-ray absorptiometry-shows great premise for charting the course of cachexia. Quantitative and qualitative changes to adipose tissue, organs, and muscle compartments, particularly of the trunk and extremities, could present important biomarkers for phenotyping cachexia and determining its onset in patients. In this review, we present and compare the imaging techniques that have been used in the setting of cancer cachexia. Their individual limitations, drawbacks in the face of clinical routine care, and relevance in oncology are also discussed.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Review
Thesis type
Editors
Keywords
Adipose Tissue ; Cancer Cachexia Progression ; Computed Tomography (ct) ; Imaging Biomarkers ; Imaging-based Phenotyping ; Magnetic Resonance Imaging (mri) ; Skeletal Muscle; Brown Adipose-tissue; X-ray Absorptiometry; Body-composition; Muscle Mass; Computed-tomography; Clinical-implications; Energy-expenditure; Fat; Sarcopenia; Prevalence
Keywords plus
Language
english
Publication Year
2021
Prepublished in Year
HGF-reported in Year
2021
ISSN (print) / ISBN
2191-219X
e-ISSN
2191-219X
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 11,
Issue: 1,
Pages: ,
Article Number: 94
Supplement: ,
Series
Publisher
Springer
Publishing Place
One New York Plaza, Suite 4600, New York, Ny, United States
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30201 - Metabolic Health
90000 - German Center for Diabetes Research
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-502591-001
G-501900-251
G-501900-253
Grants
Deutsche Forschungsgemeinschaft
Copyright
Erfassungsdatum
2021-11-12